Development of a surveillance system for methicillin-resistant Staphylococcus aureus in German hospitals

Infection Control and Hospital Epidemiology

Volumn 28, Issue 4, 2007, Pages 446-452

  Chaberny, Iris F ^a,c   Sohr, Dorit ^b,c   Rüden, Henning ^b,c   Gastmeier, Petra ^a,c  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b HUMBOLDT UNIVERSITY   (Germany)

^c German National Reference Center for Surveillance of Nosocomial Infections   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BACTERIAL COLONIZATION; CALCULATION; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; GERMANY; HEALTH CARE SYSTEM; HOSPITAL ADMISSION; HOSPITAL BASED CASE CONTROL STUDY; HOSPITAL INFECTION; HUMAN; INFECTION CONTROL; INFECTION RISK; MAJOR CLINICAL STUDY; MEDICAL RECORD; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MORBIDITY; MULTICENTER STUDY; PATHOGENESIS; PREVALENCE; SCREENING TEST; STAPHYLOCOCCUS INFECTION;

COHORT STUDIES; CROSS INFECTION; GERMANY; HOSPITALS; HUMANS; METHICILLIN RESISTANCE; POPULATION SURVEILLANCE; PROSPECTIVE STUDIES; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 33847744450     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.1086/513444     Document Type: Article

References (29)

1. National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004. Am J Infect Control 2004; 32:470-485.
2. EARSS. European Antimicrobiol Resistance Surveillance System. Annual Report. Bilthoven: ESCMID; 2002.
3. Global consensus conference: final recommendations. Am J Infect Control 1999; 27:503-513.
4. Abramson MA, Sexton DJ. Nosocomial methicillin-resistant and methicillin-susceptible Staphylococcus aureus primary bacteremia: at what costs? Infect Control Hosp Epidemiol 1999; 20:408-411.
5. Cosgrove SE, Sakoulas G, Perencevich EN, Schwaber MJ, Karchmer AW, Carmeli Y. Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis. Clin Infect Dis 2003; 36:53-59.
6. Engemann JJ, Carmeli Y, Cosgrove SE, et al. Adverse clinical and economic outcomes attributable to methicillin resistance among patients with Staphylococcus aureus surgical site infection. Clin Infect Dis 2003; 36:592-598.
7. Kirkland KB, Weinstein JM. Adverse effects of contact isolation. Lancet 1999; 354:1177-1178.
8. Whitby M, McLaws ML, Berry G. Risk of death from methicillin-resistant Staphylococcus aureus bacteraemia: a meta-analysis. Med J Aust 2001; 175:264-267.
9. Chaberny IF, Ziesing S, Mattner F, et al. The burden of MRSA in four German university hospitals. Int J Hyg Environ Health 2005; 208:447-453.
10. Tiemersma EW, Bronzwaer SL, Lyytikainen O, et al. Methicillin-resistant Staphylococcus aureus in Europe, 1999-2002. Emerg Infect Dis 2004; 10: 1627-1634.
11. German National Reference Center for Surveillance of Nosocomial Infections (Nationales Referenzzentrum für Surveillance von nosokomialen Infektionen [NRZ]). Available at: http://www.nrz-hygiene.de. Accessed March 3, 2007.
12. Empfehlung zur Prävention und Kontrolle von Methicillin-resistenten Staphylococcus aureus-Stämmen (MRSA) in Krankenhäusern und anderen medizinischen Einrichtungen: Mitteilung der Kommission für Krankenhaushygiene und Infektionsprävention am Robert Koch-Institut. Bundesgesundheitsblatt 1999; 42:954-958.
13. Jarvis WR, Edwards JR, Culver DH, et al. Nosocomial infection rates in adult and pediatric intensive care units in the United States. National Nosocomial Infections Surveillance System. Am J Med 1991; 91:185S-191S.
14. Merrer J, Santoli F, Appere de Vecchi C, Tran B, De Jonghe B, Outin H. "Colonization pressure" and risk of acquisition of methicillin-resistant Staphylococcus aureus in a medical intensive care unit. Infect Control Hosp Epidemiol 2000; 21:718-723.
15. Haley RW. Surveillance by objective: a new priority-directed approach to the control of nosocomial infections. The National Foundation for Infectious Diseases lecture. Am J Infect Control 1985; 13:78-89.
16. Kresken M, Hafner D, Schmitz F-J, Wichelhaus TA. Resistenzsituation bei klinisch wichtigen Infektionserregern gegenüber Antibiotika in Deutschland und im mitteleuropäischen Raum: Bericht über die Ergebnisse einer multizentrischen Studie der Arbeitsgemeinschaft Empfindlichkeitsprüfungen und Resistenz der Paul-Ehrlich-Gesellschaft für Chemotherapie e.V. aus dem Jahre 2001. Antiinfectives Intelligence, Rheinbach 2006;1:14-15. Available at http://www.p-e-g.org/ag_resistenz/main.htm. Accessed March 3, 2007.
17. Gastmeier P, Sohr D, Geffers C, Nassauer A, Dettenkofer M, Ruden H. Occurrence of methicillin-resistant Staphylococcus aureus infections in German intensive care units. Infection 2002; 30:198-202.
18. The Hopital Propre II Study Group. Methicillin-resistant Staphylococcus aureus in French hospitals: a 2-month survey in 43 hospitals, 1995. Infect Control Hosp Epidemiol 1999; 20:478-486.
19. Eveillard M, Schmit JL, Biendo M, et al. Evaluation of the efficacy of a multiresistant bacteria control programme in a teaching hospital, studying the evolution of methicillin-resistant Staphylococcus aureus incidence [in French]. Pathol Biol (Paris) 2002; 50:538-543.
20. Lepelletier D, Richet H. Surveillance and control of methicillin- resistant Staphylococcus aureus infections in French hospitals. Infect Control Hosp Epidemiol 2001; 22:677-682.
21. McDonald P, Mitchell E, Johnson H, et al. Epidemiology of MRSA: the North/South study of MRSA in Ireland 1999. J Hosp Infect 2003; 54: 130-134.
22. Albertini MT, Benoit C, Berardi L, et al. Surveillance of methicillin-resistant Staphylococcus aureus (MRSA) and Enterobacteriaceae producing extended-spectrum beta-lactamase (ESBLE) in Northern France: a five-year multicentre incidence study. J Hosp Infect 2002; 52:107-113.
23. Assadian O, Daxboeck F, Aspoeck C, Blacky A, Dunkl R, Koller W. National surveillance of methicillin-sensitive and methicillin-resistant Staphylococcus aureus in Austrian hospitals: 1994-1998. J Hosp Infect 2003; 55:175-179.
24. Simor AE, Ofner-Agostini M, Bryce E, Green K, McGeer A, Mulvey M, Paton S. The evolution of methicillin-resistant Staphylococcus aureus in Canadian hospitals: 5 years of national surveillance. CMAJ 2001; 165: 21-26.
25. Struelens MJ, Ronveaux O, Jans B, Mertens R. Methicillin-resistant Staphylococcus aureus epidemiology and control in Belgian hospitals, 1991 to 1995. Groupement pour le Depistage, l'Etude et la Prevention des Infections Hospitalieres. Infect Control Hosp Epidemiol 1996; 17:503-508.
26. Bonten MJ, Slaughter S, Ambergen AW, et al. The role of "colonization pressure" in the spread of vancomycin-resistant enterococci: an important infection control variable. Arch Intern Med 1998; 158:1127-1132.
27. Lucet JC, Paoletti X, Lolom I, et al. Successful long-term program for controlling methicillin-resistant Staphylococcus aureus in intensive care units. Intensive Care Med 2005; 31:1051-1057.
28. Eveillard M, Lancien E, Hidri N, et al. Estimation of methicillin-resistant Staphylococcus aureus transmission by considering colonization pressure at the time of hospital admission. J Hosp Infect 2005; 60:27-31.
29. Pittet D, Safran E, Harbarth S, et al. Automatic alerts for methicillin-resistant Staphylococcus aureus surveillance and control: role of a hospital information system. Infect Control Hosp Epidemiol 1996; 17:496-502.